University of California Los Angeles (UCLA) is a clinical research site located in Santa Monica, California, United States 90095.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
University of California Los Angeles (UCLA) has participated in 8 clinical trials with 4 currently active.
Therapeutic areas: Metastatic Colorectal Cancer, Endometrial Adenocarcinoma, Diffuse Large B-cell Lymphoma.
Sponsors: Gilead Sciences, Acrivon Therapeutics, Karyopharm Therapeutics Inc.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of California Los Angeles (UCLA) has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of California Los Angeles (UCLA) has 8 clinical trials on record, with 4 currently active. Their work covers Metastatic Colorectal Cancer, Endometrial Adenocarcinoma, Diffuse Large B-cell Lymphoma.
Yes — University of California Los Angeles (UCLA) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.